453 related articles for article (PubMed ID: 21760596)
1. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.
Melino G
Cell Death Differ; 2011 Sep; 18(9):1487-99. PubMed ID: 21760596
[TBL] [Abstract][Full Text] [Related]
2. p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.
Su X; Chakravarti D; Flores ER
Nat Rev Cancer; 2013 Feb; 13(2):136-43. PubMed ID: 23344544
[TBL] [Abstract][Full Text] [Related]
3. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
Roberts O; Paraoan L
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.
Muller PA; Trinidad AG; Caswell PT; Norman JC; Vousden KH
J Biol Chem; 2014 Jan; 289(1):122-32. PubMed ID: 24220032
[TBL] [Abstract][Full Text] [Related]
5. A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.
Subramanian M; Francis P; Bilke S; Li XL; Hara T; Lu X; Jones MF; Walker RL; Zhu Y; Pineda M; Lee C; Varanasi L; Yang Y; Martinez LA; Luo J; Ambs S; Sharma S; Wakefield LM; Meltzer PS; Lal A
Oncogene; 2015 Feb; 34(9):1094-104. PubMed ID: 24662829
[TBL] [Abstract][Full Text] [Related]
6. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.
Yoh KE; Regunath K; Guzman A; Lee SM; Pfister NT; Akanni O; Kaufman LJ; Prives C; Prywes R
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6107-E6116. PubMed ID: 27681615
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome.
Neilsen PM; Noll JE; Suetani RJ; Schulz RB; Al-Ejeh F; Evdokiou A; Lane DP; Callen DF
Oncotarget; 2011 Dec; 2(12):1203-17. PubMed ID: 22203497
[TBL] [Abstract][Full Text] [Related]
8. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
9. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
10. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to cancer treatment using structural hybrids of the p53 gene family.
Sasaki Y; Oshima Y; Koyama R; Tamura M; Kashima L; Idogawa M; Yamashita T; Toyota M; Imai K; Shinomura Y; Tokino T
Cancer Gene Ther; 2012 Nov; 19(11):749-56. PubMed ID: 22956039
[TBL] [Abstract][Full Text] [Related]
12. p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.
Gatti V; Bongiorno-Borbone L; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159154
[TBL] [Abstract][Full Text] [Related]
13. p63 expression defines a lethal subset of muscle-invasive bladder cancers.
Choi W; Shah JB; Tran M; Svatek R; Marquis L; Lee IL; Yu D; Adam L; Wen S; Shen Y; Dinney C; McConkey DJ; Siefker-Radtke A
PLoS One; 2012; 7(1):e30206. PubMed ID: 22253920
[TBL] [Abstract][Full Text] [Related]
14. OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.
Ng WL; Chen G; Wang M; Wang H; Story M; Shay JW; Zhang X; Wang J; Amin AR; Hu B; Cucinotta FA; Wang Y
Cell Death Dis; 2014 Jan; 5(1):e1024. PubMed ID: 24457968
[TBL] [Abstract][Full Text] [Related]
15. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
Buckley NE; D'Costa Z; Kaminska M; Mullan PB
Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic roles of EMT-inducing transcription factors.
Puisieux A; Brabletz T; Caramel J
Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
[TBL] [Abstract][Full Text] [Related]
17. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
Ory B; Ellisen LW
Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
[TBL] [Abstract][Full Text] [Related]
18. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
19. Maintaining epithelial stemness with p63.
Melino G; Memmi EM; Pelicci PG; Bernassola F
Sci Signal; 2015 Jul; 8(387):re9. PubMed ID: 26221054
[TBL] [Abstract][Full Text] [Related]
20. The microRNA feedback regulation of p63 in cancer progression.
Lin C; Li X; Zhang Y; Guo Y; Zhou J; Gao K; Dai J; Hu G; Lv L; Du J; Zhang Y
Oncotarget; 2015 Apr; 6(11):8434-53. PubMed ID: 25726529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
